Anavex Life Sciences Corp (AVXL)

[georgejjl]

Clinical study ANAVEX® 2-73

The first phase of the ANAVEX® 2-73 trials for Parkinson's disease with associated dementia was carried out thanks to a research grant awarded by the Michael J. Fox Foundation for Parkinson's disease research, a foundation created by the well-known American actor of the same name who suffers from this disease. The second phase of the study is being developed entirely in Spain. Currently, 20 hospitals throughout the national territory are actively participating, which aims to bring together a total of 150 patients participating in the study. However, research is already under way in some hospitals.

The Spanish hospitals participating in the study are: HM Puerta del Sur Hospital (Móstoles), Infanta Leonor Hospital (Madrid), Henares Hospital (Coslada), Gregorio Marañón General University Hospital (Madrid), La Princesa Hospital (Madrid), San Carlos Clinical Hospital (Madrid), Ramón y Cajal Hospital (Madrid), Ruber International Clinic (Madrid), Puerta del Mar University Hospital (Cádiz), Virgen del Rocío University Hospital (Seville), General University Hospital of Elche (Elche), Hospital Sant Joan de Reus (Reus), Hospital of Santa Creu i Sant Pau (Barcelona), Vall d'Hebron University Hospital (Barcelona), Santa Caterina Hospital (Girona), University Hospital of Navarra (CUN) (Navarra), Hospital University of Burgos (Burgos), Central University Hospital of Asturias (Oviedo),University Clinical Hospital of Santiago de Compostela (Santiago de Compostela), Architect Hospital Marcide (Ferrol).

https://www.gacetamedica.com/especializada/comienza-la-segunda-fase-del-estudio-clinico-para-enfermedad-de-parkinson-con-demencia-asociada-MG1945349

Good luck and GOD bless,